Delivery Order SPE2DB22D2006-SPE2DB25FV8VX

Award Date 3/4/25
Potential Completion Date 3/5/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,686.80 firm-fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has a ceiling value of $9,686.80 and an ultimate completion date of December 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,333.68 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of November 25, 2024 and was awarded on November 22, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,085.84 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of August 27, 2021. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,095.31 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of December 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,661.39, is a delivery order for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of February 21, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,995.10 firm fixed-price delivery order contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has a completion date of June 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,808.93 firm-fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,963.28 delivery order contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has a firm fixed-price pricing type and an ultimate completion date of October 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,165.80 firm fixed price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of July 10, 2024 and was awarded on July 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,745.24 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of April 30, 2024 and was awarded on April 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV8VX
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,554.40 firm fixed-price delivery order is for the supply of 4567458152 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract has no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 6/3/25, 9:48 AM